Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Study on Early Esophageal Cancer Detection: Circulating Tumor DNA Methylation Biomarkers in Liquid Biopsy

NCT06895551 is registered in ClinicalTrials.gov with Singlera Genomics Inc. as lead sponsor.

NCT NCT06895551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06895551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Study on Early Esophageal Cancer Detection: Circulating Tumor DNA Methylation Biomarkers in Liquid Biopsy
Lead sponsor
Singlera Genomics Inc.
Phase
Observational
Overall status
Completed
Start date
September 1, 2022
Completion date
February 20, 2025
Enrollment
1,069 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer